Post-proteasomal antigen processing for major histocompatibility complex class I presentation

Nature Immunology
Kenneth L RockAlfred L Goldberg

Abstract

Peptides presented by major histocompatibility complex class I molecules are derived mainly from cytosolic oligopeptides generated by proteasomes during the degradation of intracellular proteins. Proteasomal cleavages generate the final C terminus of these epitopes. Although proteasomes may produce mature epitopes that are eight to ten residues in length, they more often generate N-extended precursors that are too long to bind to major histocompatibility complex class I molecules. Such precursors are trimmed in the cytosol or in the endoplasmic reticulum by aminopeptidases that generate the N terminus of the presented epitope. Peptidases can also destroy epitopes by trimming peptides to below the size needed for presentation. In the cytosol, endopeptidases, especially thimet oligopeptidase, and aminopeptidases degrade many proteasomal products, thereby limiting the supply of many antigenic peptides. Thus, the extent of antigen presentation depends on the balance between several proteolytic processes that may generate or destroy epitopes.

References

Jan 1, 1995·Methods in Enzymology·A J BarrettA Serizawa
Apr 1, 1995·The Journal of Experimental Medicine·T ElliottA Townsend
Feb 1, 1995·Current Opinion in Immunology·H G Rammensee
Nov 1, 1994·The Journal of Experimental Medicine·J RoelseJ Neefjes
Dec 1, 1994·The Journal of Experimental Medicine·H L SnyderJ R Bennink
Sep 1, 1994·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·D M OjciusP Kourilsky
May 1, 1994·The Journal of Experimental Medicine·F MomburgJ J Neefjes
Feb 1, 1994·Current Opinion in Immunology·F MomburgG J Hämmerling
Aug 1, 1996·European Journal of Immunology·J O KoopmannF Momburg
Oct 6, 1997·Proceedings of the National Academy of Sciences of the United States of America·A CraiuK L Rock
Jun 8, 1999·Annual Review of Immunology·K L Rock, A L Goldberg
Sep 2, 1999·Trends in Biochemical Sciences·B Tomkinson
Jan 13, 2000·Immunological Reviews·I A YorkK L Rock
May 9, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·D LópezM Del Val
May 29, 2000·European Journal of Biochemistry·L SchomburgK Bauer
Jun 8, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·K SchwarzM Groettrup
Mar 23, 2001·Nature Immunology·L StoltzeH Schild
Jul 24, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·C KnuehlP M Kloetzel
Oct 3, 2001·Journal of Structural Biology·A Y DunnJ Frydman

❮ Previous
Next ❯

Citations

May 17, 2005·Immunogenetics·Bjoern PetersAlessandro Sette
Jan 14, 2005·Cancer Immunology, Immunotherapy : CII·Thomas FelzmannWolfgang Holter
Jul 7, 2009·Human Genetics·Matthew P JohnsonEric K Moses
Aug 30, 2005·The International Journal of Biochemistry & Cell Biology·Birgitta Tomkinson, Ann-Christin Lindås
Apr 14, 2012·Molecular Pharmaceutics·Ivo R RuttekolkRoland Brock
Jan 6, 2011·Journal of Proteome Research·Julia S GelmanLloyd D Fricker
Dec 15, 2010·Nature Immunology·Jan H KesslerCornelis J M Melief
Oct 4, 2011·Nature Immunology·Xiao Z ShenKenneth E Bernstein
Jun 30, 2004·Nature Immunology·Anne L Ackerman, Peter Cresswell
Sep 20, 2007·Nature Immunology·Peter E Jensen
May 3, 2007·Nature Reviews. Drug Discovery·Anthony W PurcellJamie Rossjohn
Jan 24, 2009·Nature Reviews. Molecular Cell Biology·Shigeo MurataKeiji Tanaka
Apr 12, 2011·Nature Structural & Molecular Biology·Tina T NguyenLawrence J Stern
Jun 29, 2011·Proceedings of the National Academy of Sciences of the United States of America·Sebastien ApcherRobin Fåhraeus
Aug 12, 2009·The Journal of Biological Chemistry·Ruth Geiss-FriedlanderFrauke Melchior
Aug 16, 2013·Journal of Biochemistry·Akira Hattori, Masafumi Tsujimoto
Jun 2, 2007·Science·Shigeo MurataKeiji Tanaka
Mar 18, 2005·Annual Review of Immunology·E Sergio Trombetta, Ira Mellman
Nov 13, 2013·The Journal of Clinical Investigation·Jaba GamrekelashviliTim F Greten
Oct 29, 2004·PLoS Biology·Susan R SchwabNilabh Shastri
May 23, 2012·PLoS Computational Biology·Ilka HoofCan Keşmir
Oct 21, 2004·Biological Chemistry·Cynthia Anne WrightSebastian Springer
Nov 3, 2007·Biological Chemistry·Tina Zavasnik-Bergant, Boris Turk
Jan 5, 2014·Amino Acids·Sarina M HitzerdGodefridus J Peters
Jul 21, 2005·Proceedings of the National Academy of Sciences of the United States of America·Andréa TomaChristian Boitard

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.